# OnCo record paper-upadhaya-nat-rev-drug-discov (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-upadhaya-nat-rev-drug-discov/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-upadhaya-nat-rev-drug-discov" ;
  schema:name "Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape"@en ;
  schema:description "Paper cited by two bottleneck pages and eleven idea pages, indexed on Europe PMC as PubMed record 35145263 and published in Nature Reviews Drug Discovery; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-upadhaya-nat-rev-drug-discov/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/d41573-022-00030-4>, <https://pubmed.ncbi.nlm.nih.gov/35145263/>, <https://europepmc.org/article/MED/35145263> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/d41573-022-00030-4> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Upadhaya S, Neftelinov ST, Hodge J, et al." ;
  onco:related <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-combination-space/>, <https://onco.cc/ideas/idea-fund-repurposing-indication-exclusivity/>, <https://onco.cc/ideas/idea-fund-abbreviated-pathway-me-too-biologics/>, <https://onco.cc/ideas/idea-fund-duration-trial-exclusivity/>, <https://onco.cc/ideas/idea-fund-phase-two-failure-reinsurance/>, <https://onco.cc/ideas/idea-fund-public-car-t-manufacturing/>, <https://onco.cc/ideas/idea-fund-first-in-class-prize/>, <https://onco.cc/ideas/idea-fund-pay-for-cure-annuities/>, <https://onco.cc/ideas/idea-fund-value-based-patent-extension/>, <https://onco.cc/ideas/idea-fund-head-to-head-mandate/>, <https://onco.cc/ideas/idea-fund-benefit-indexed-exclusivity/>, <https://onco.cc/ideas/idea-fund-social-impact-bonds-prevention/> ;
  onco:journals <https://onco.cc/journals/nature-reviews-drug-discovery/> .